Article
Mutation specific therapy in CF.
Paediatric respiratory reviews - 1 Jan 2006
Kerem Eitan
Abstract excerpt
CFTR mutations cause defects of CFTR protein production and function by different molecular mechanisms. The mutations can be classified according to the mechanisms by which mutations disrupt CFTR function. This understanding of the different molecular mechanism of CFTR dysfunction provides the scientific basis for development of targeted drugs for mutation specific therapy of CF. Class I mutations are nonsense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
